Trial Profile
Adalimumab with concomitant enteral nutrition therapy in patients with Crohn's disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Aug 2014
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 09 Aug 2014 New trial record